Steinhaus, Daniel A. MD; Lubitz, Steven A. MD, MPH; Noseworthy, Peter A. MD; Kramer, Daniel B. MD, MPH
Saint Luke's Mid America Heart Institute, Kansas City, Missouri (Dr Steinhaus); Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (Dr Kramer); Cardiac Arrhythmia Service, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (Dr Lubitz); and Cardiovascular Division, Department of Medicine, Mayo Clinic, Rochester, Minnesota (Dr Noseworthy).
Correspondence: Daniel A. Steinhaus, MD, Saint Luke's Mid America Heart Institute, 4330 Wornall Rd, Ste 2000, Kansas City, MO 64111 ([email protected]).
Dr Steinhaus has consulted for Abbott Laboratories and Boston Scientific and has a family member who is an executive for Medtronic. Dr Lubitz receives sponsored research support from Bayer HealthCare, Biotronik, and Boehringer Ingelheim, and has consulted for St Jude Medical and Quest Diagnostics. Dr Noseworthy has no disclosures to report regarding this publication. Dr Kramer has consulted to the Baim Institute for Clinical Research for clinical trials of medical devices.Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.jcrpjournal.com).